Envoy Medical, Inc. - Class A (COCH) earnings
COCH earnings moved a median of +2.27% by the close. Quarterly and annual COCH reports and results, each read against the price at its own news timestamp. Back to the COCH overview →
14 measured COCH earnings events.
Where these COCH earnings landedvs 13 measured COCH earnings reactions
| Middle 50% of COCH earnings reactions | -4.41% to +4.50% |
|---|---|
| Median reaction (to close) | +2.27% |
| Measured reactions | 13 |
Point-in-time · zero look-ahead
Half of the 13 COCH earnings events with a measured close landed between -4.41% and +4.50%; 54% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Envoy Medical, Inc. For: Jun 30 | SEC filing · Form 10-Q | +1.88% | — | |
| Form 10-Q Envoy Medical, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -6.67% | |
| Form 10-K/A Envoy Medical, Inc. For: Dec 31 | SEC filing · Form 10-K | -0.63% | +3.97% | |
| Form 10-K Envoy Medical, Inc. For: Dec 31 | SEC filing · Form 10-K | +1.31% | -6.33% | |
| Form 10-Q Envoy Medical, Inc. For: Sep 30 | SEC filing · Form 10-Q | -1.03% | -2.74% | |
| Form 10-Q Envoy Medical, Inc. For: Jun 30 | SEC filing · Form 10-Q | +5.92% | -3.94% | |
| Form 10-Q Envoy Medical, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -7.53% | |
| Form 10-K Envoy Medical, Inc. For: Dec 31 | SEC filing · Form 10-K | +2.57% | -4.41% | |
| Envoy Medical Reports Third Quarter 2024 Results and Other Exciting Events | Press release | +1.54% | +9.23% | |
| Form 10-Q Envoy Medical, Inc. For: Sep 30 | SEC filing · Form 10-Q | +1.54% | +9.23% | |
| Envoy Medical Reports Second Quarter 2024 Results and Provides Business Update | Press release | -1.51% | +2.27% | |
| Form 10-Q Envoy Medical, Inc. For: Jun 30 | SEC filing · Form 10-Q | -1.51% | +2.27% | |
| Envoy Medical Reports First Quarter 2024 Results | Press release | +0.00% | +4.50% | |
| Envoy Medical Provides Third Quarter 2023 Financial Results and Business Update | Press release | — | +18.15% |
Keep exploring
More COCH: analyst actions → · SEC filings → · COCH overview →